The survival rate for children with congenital heart disease (CHD) has increased significantly coincident with improved techniques in cardiothoracic surgery, cardiopulmonary bypass and myocardial protection, and perioperative care. Cardiopulmonary bypass, likely in combination with ischemia—reperfusion injury, hypothermia, and surgical trauma, elicits a complex, systemic inflammatory response that is characterized by activation of the complement cascade, release of endotoxin, activation of leukocytes and the vascular endothelium, and release of proinflammatory cytokines. This complex inflammatory state causes a transient immunosuppressed state, which may increase the risk of hospital-acquired infection in these children. Postoperative sepsis occurs in nearly 3% of children undergoing cardiac surgery and has been associated with longer length of stay and mortality risks in the pediatric cardiac intensive care unit. Herein, we review the epidemiology, pathobiology, and management of sepsis in the pediatric cardiac intensive care unit.
BoneRCFisherCJClemmerTPSlotmanGJMetzCABalkRA.Sepsis syndrome: a valid clinical entity. Crit Care Med. 1989;17(5):389–393.
2.
ACCPSCCM. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864–874.
3.
GoldsteinBGiroirBRandolphA.International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2–8.
4.
HadzimuratovicEDinarevicSMHadzimuratovicA.Sepsis in premature newborns with congenital heart disease. Congenit Heart Dis. 2010;5(5):435–438.
5.
DoellCBernetVMolinariLBeckIBalmerCLatalB.Children with genetic disorders undergoing open-heart surgery: are they at increased risk for postoperative complications?Pediatr Crit Care Med. 2010;
6.
BarkerGMO’BrienSMWelkeKF. Major infection after pediatric cardiac surgery: a risk estimation model. Ann Thorac Surg. 2010;89(3):843–850.
7.
LevyIOvadiaBErezE. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. J Hosp Infect. 2003;53(2):111–116.
8.
SarikiviELyytikainenONieminenHSairanenHSaxénH.Nosocomial infections after pediatric cardiac surgery. Am J Infect Control. 2008;36(8):564–569.
9.
MehtaPACunninghamCKColellaCBAlferisGWeinerLB.Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J. 2000;19(10):1000–1004.
10.
ChakrabartiCSoodSKParnellVRubinLG.Prolonged candidemia in infants following surgery for congenital heart disease. Infect Control Hosp Epidemiol. 2003;24(10):753–757.
11.
San MiguelLGCoboJOtheoE. Candidemia in pediatric patients with congenital heart disease. Diagn Microbiol Infect Dis. 2006;55(3):203–207.
12.
Abou ElellaRNajmHKBalkhyH. Impact of bloodstream infection on the outcome of children undergoing cardiac surgery. Pediatr Cardiol. 2010;31(4):483–489.
13.
LomtadzeMChkhaidzeMMgeladzeEMetreveliITsintsadzeA.Incidence and risk factors of nosocomial infections after cardiac surgery in Georgian population with congenital heart diseases. Georgian Med News. 2010;178:7–11.
14.
TangCWLiuPYHuangYF. Ventilator-associated pneumonia after pediatric cardiac surgery in southern Taiwan. J Microbiol Immunol Infect. 2009;42(5):413–419.
15.
MarshallJC.SIRS and MODS: What is their relevance to the science and practice of intensive care?Shock. 2000;14(6):586–589.
16.
BaueAE.A debate on the subject “Are SIRS and MODS important entities in the clinical evaluation of patients?” The con position. Shock. 2000;14(6):590–593.
17.
VincentJL.Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med. 1997;25(2):372–374.
18.
LevyMMFinkMPMarshallJC. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–1256.
19.
DenoixPX.Enquete permanent dans les centres anticancereaux. Bull Inst Natl Hyg. 1946;1(5):70–75.
20.
OpalSM.Concept of PIRO as a new conceptual framework to understand sepsis. Pediatr Crit Care Med. 2005;6(3 suppl):S55–S60.
21.
HowellMDTalmorDSchuetzPHunzikerSJonesAEShapiroNI.Proof of principle: The predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39(2):322–327.
22.
MorenoRPMetnitzBAdlerL. Sepsis mortality prediction based on predisposition, infection, and response. Intensive Care Med. 2008;34(3):496–504.
23.
RubulottaFMarshallJRamsayGNelsonDLevyMWilliamsM.Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis. Crit Care Med. 2009;37(4):1329–1335.
24.
RelloJRodriguezALisboaTGallegoMLujanMWunderinkR.PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med. 2009;37(2):456–462.
25.
WatsonRSCarcilloJALinde-ZwirbleWTClermontGLidickerJAngusDC.The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167(5):695–701.
26.
AngusDCLinde-ZwirbleWTLidickerJClermontGCarcilloJPinskyMR.Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310.
27.
WynnJCornellTTWongHR. The host response to sepsis and developmental impact. Pediatrics. 2010;125(5):1031–1041.
28.
MarriottIHuet-HudsonYM.Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res. 2006;34(3):177–192.
29.
ChoudhryMABlandKIChaudryIH.Trauma and immune response–effect of gender differences. Injury. 2007;38(12):1382–1391.
30.
CarcilloJA.Reducing the global burden of sepsis in infants and children: A clinical practice research agenda. Pediatr Crit Care Med. 2005;6(3 suppl):S157–S164.
31.
NguyenTHNguyenTLLeiHY. Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005;72(4):370–374.
32.
SakrYMadlCFilipescuD. Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med. 2008;34(11):1999–2009.
33.
WheelerDSZingarelliBWheelerWJWongHR.Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response. Recent Pat Inflamm Allergy Drug Discov. 2009;3(2):96–112.
34.
DahmerMKRandolphAVitaliSQuasneyMW.Genetic polymorphisms in sepsis. Pediatr Crit Care Med. 2005;6(3 suppl):S61–S73.
35.
CuadradoEBarrenaMJ.Immune dysfunction in Down’s syndrome: primary immune deficiency or early sensescence of the immune system?Clin Immunol Immunopathol. 1996;78(3):209–214.
36.
NespoliLBurgioGRUgazioAGMaccarioR.Immunological features of Down’s syndrome: a review. J Intellect Disabil Res. 1993;37(pt 6):543–551.
37.
FridCAnnerenGRasmussenFSundelinCDrottP.Utilization of medical care among children with Down’s syndrome. J Intellect Disabil Res. 2002;46(pt 4):310–317.
38.
GarrisonMMJeffriesHChristakisDA.Risk of death for children with Down syndrome and sepsis. J Pediatr. 2005;147(6):748–752.
39.
EltzschigHKCarmelietP.Hypoxia and inflammation. N Engl J Med. 2011;364(7):656–665.
40.
CostelloJMGrahamDAMorrowDFPotter-BynoeGSandoraTJLaussenPC.Risk factors for central line-associated bloodstream infection in a pediatric cardiac intensive care unit. Pediatr Crit Care Med. 2009;10(4):453–459.
41.
CostelloJMMorrowDFGrahamDAPotter-BynoeGSandoraTJLaussenPC.Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics. 2008;121(5):915–923.
42.
WylieMCGrahamDAPotter-BynoeG. Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol. 2010;31(10):1049–1056.
43.
CostelloJMGrahamDAMorrowDF. Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg. 2010;89(6):1833–1842.
44.
TarnokASchneiderP.Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. Shock. 2001;16(suppl 1):24–32.
45.
AllenMLHoschtitzkyJAPetersMJ. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med. 2006;34(10):2658–2665.
46.
AllenMLPetersMJGoldmanA. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med. 2002;30(5):1140–1145.
47.
CavaillonJ-MAdrieCFittingCAdib-ConquyM.Endotoxin tolerance: is there a clinical relevance?J Endotoxin Res. 2003;9(2):101–107.
48.
PollockEMFord-JonesELRebeykaI. Early noscomial infections in pediatric cardiovascular surgery patients. Crit Care Med. 1990;18(4):378–384.
49.
OpalSMCohenJ.Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?Crit Care Med. 1999;27(8):1608–1616.
50.
MoinePAbrahamE.Immunomodulation and sepsis: impact of the pathogen. Shock. 2004;22(4):297–308.
51.
van der PollTOpalSM.Host-pathogen interactions in sepsis. Lancet Infect Dis. 2008;8(1):32–43.
52.
CookeGSHillAV.Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001;2(12):967–977.
53.
CornellTTWynnJShanleyTPWheelerDSWongHR.Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics. 2010;125(6):1248–1258.
54.
WheelerDSWongHR.Genetic approach to pediatric septic shock. Personalized Med. 2008;5(2):249–263.
55.
SorensenTINielsenGGAndersenPKTeasdaleTW.Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988;318(12):727–732.
56.
OsuchowskiMFWelchKSiddiquiJRemickDG.Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol. 2006;177(3):1967–1974.
57.
AshareAPowersLSButlerNSDoerschugKCMonickMMHunninghakeGW.Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol. 2005;288(4):L633–L640.
58.
DockeWDRandowFSyrbeU. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med. 1997;3(6):678–681.
59.
VolkHDReinkePKrauschD. Monocyte deactivation–rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996;22(suppl 4):S474–S481.
60.
KoxWJBoneRCKrauschD. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch Intern Med. 1997;157(4):389–393.
61.
BundschuhDSBarsigJHartungT. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol. 1997;158(6):2862–2871.
62.
PuginJ.Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp. 2007;280:21-36, 160-164.
63.
NelsonLA.Use of granulocyte-macrophage colony-stimulating factor to reverse anergy in otherwise immunologically healthy children. Ann Allergy Asthma Immunol. 2007;98(4):373–382.
64.
SpightDTrapnellBZhaoB. Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice. Shock. 2008;30(4):434–442.
65.
FloheSBAgrawalHFloheSRaniMBangenJMSchadeFU.Diversity of interferon gamma and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis. Mol Med. 2008;14(5-6):247–256.
66.
MonneretGVenetFPachotALepapeA.Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol Med. 2008;14(1-2):64–78.
67.
KaplanJMWongHR.Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med. 2011;12:165-173;
68.
WongHRWheelerDSTegtmeyerK. Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit Care Med. 2010;38(10):1955–1961.
69.
SeghayeMCEngelhardtWGrabitzRG. Multiple system organ failure after open heart surgery in infants and children. Thorac Cardiovasc Surg. 1993;41(1):49–53.
70.
ShimeNKageyamaKAshidaHTanakaY.Application of modified sequential organ failure assessment score in children after cardiac surgery. J Cardiothorac Vasc Anesth. 2001;15(4):463–468.
71.
Ben-AbrahamREfratiOMishaliD. Predictors for mortality after prolonged mechanical ventilation after cardiac surgery in children. J Crit Care. 2002;17(4):235–239.
72.
AroraPKherVRaiPKSinghalMKGulatiSGuptaA.Prognosis of acute renal failure in children: a multivariate analysis. Pediatr Nephrol. 1997;11(2):153–155.
73.
BunchmanTEMcBrydeKDMottesTEGardnerJJMaxvoldNJBrophyPD.Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol. 2001;16(12):1067–1071.
74.
OtukeshHHoseiniRHoomanN. Prognosis of acute renal failure in children. Pediatr Nephrol. 2006;21(5):1873–1878.
75.
ZappitelliMBernierPLSaczkowskiRS. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int. 2009;76(8):885–892.
76.
CarcilloJAFieldsAI.Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med. 2002;30(6):1365–1378.
77.
HanYYCarcilloJADragottaMA. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics. 2003;112(4):793–799.
78.
OliveiraCFNogueira de SaFROliveiraDS. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: Barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world. Pediatr Emerg Care. 2008;24(12):810–815.
79.
de OliveiraCFde OliveiraDSGottschaldAF. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: An outcomes comparison with and without monitoring of central venous oxygen saturation. Intensive Care Med. 2008;34(6):1065–1075.
80.
BrierleyJCarcilloJAChoongK. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37(4):666–688.
